Human albumin impairs amyloid β-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in alzheimer's disease

Picón-Pagès, Pol; Bonet Martínez, Jaume, 1982-; García-García, Javier, 1982-; Garcia-Buendia, Joan; Gutierrez, Daniela; Valle, Javier; Gómez-Casuso, Carmen E.S.; Sidelkivska, Valeriya; Alvarez, Alejandra; Perálvarez Marín, Alex; Suades, Albert; Fernàndez Busquets, Xavier; Andreu Martínez, David; Vicente García, Rubén, 1978-; Oliva Miguel, Baldomero; Muñoz López, Francisco José, 1964-

Human albumin impairs amyloid β-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in alzheimer's disease

Mostra el registre complet Registre parcial de l'ítem

dc.contributor.author Picón-Pagès, Pol
dc.contributor.author Bonet Martínez, Jaume, 1982-
dc.contributor.author García-García, Javier, 1982-
dc.contributor.author Garcia-Buendia, Joan
dc.contributor.author Gutierrez, Daniela
dc.contributor.author Valle, Javier
dc.contributor.author Gómez-Casuso, Carmen E.S.
dc.contributor.author Sidelkivska, Valeriya
dc.contributor.author Alvarez, Alejandra
dc.contributor.author Perálvarez Marín, Alex
dc.contributor.author Suades, Albert
dc.contributor.author Fernàndez Busquets, Xavier
dc.contributor.author Andreu Martínez, David
dc.contributor.author Vicente García, Rubén, 1978-
dc.contributor.author Oliva Miguel, Baldomero
dc.contributor.author Muñoz López, Francisco José, 1964-
dc.date.accessioned 2019-09-16T14:20:42Z
dc.date.available 2019-09-16T14:20:42Z
dc.date.issued 2019
dc.description.abstract Alzheimer's disease (AD) is a neurodegenerative process characterized by the accumulation of extracellular deposits of amyloid β-peptide (Aβ), which induces neuronal death. Monomeric Aβ is not toxic but tends to aggregate into β-sheets that are neurotoxic. Therefore to prevent or delay AD onset and progression one of the main therapeutic approaches would be to impair Aβ assembly into oligomers and fibrils and to promote disaggregation of the preformed aggregate. Albumin is the most abundant protein in the cerebrospinal fluid and it was reported to bind Aβ impeding its aggregation. In a previous work we identified a 35-residue sequence of clusterin, a well-known protein that binds Aβ, that is highly similar to the C-terminus (CTerm) of albumin. In this work, the docking experiments show that the average binding free energy of the CTerm-Aβ1-42 simulations was significantly lower than that of the clusterin-Aβ1-42 binding, highlighting the possibility that the CTerm retains albumin's binding properties. To validate this observation, we performed in vitro structural analysis of soluble and aggregated 1 μM Aβ1-42 incubated with 5 μM CTerm, equimolar to the albumin concentration in the CSF. Reversed-phase chromatography and electron microscopy analysis demonstrated a reduction of Aβ1-42 aggregates when the CTerm was present. Furthermore, we treated a human neuroblastoma cell line with soluble and aggregated Aβ1-42 incubated with CTerm obtaining a significant protection against Aβ-induced neurotoxicity. These in silico and in vitro data suggest that the albumin CTerm is able to impair Aβ aggregation and to promote disassemble of Aβ aggregates protecting neurons.
dc.description.sponsorship This work was supported by the Spanish Ministry of Economy and Business through grant Plan Estatal SAF2017-83372-R & SAF2014-52228-R (FEDER funds/UE) to FJM and RV; BIO2017-85329-R to BO; AGL2014-52395-C2 and AGL2017- 84097-C2-2-R to D.A.; MDM-2014-0370 through the “María de Maeztu” Programme for Units of Excellence in R&D to “Departament de Ciències Experimentals i de la Salut”; the Chilean Government through Fondecyt 11611065 and AFB170005 to AA, and REDES 180084 to AA and FJM; ISGlobal and IBEC are members of the CERCA Programme, Generalitat de Catalunya.
dc.format.mimetype application/pdf
dc.identifier.citation Picón-Pagès P, Bonet J, García-García J, Garcia-Buendia J, Gutierrez D, Valle J et al. Human albumin impairs amyloid β-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in alzheimer's disease. Comput Struct Biotechnol J. 2019;17:963-71. DOI: 10.1016/j.csbj.2019.06.017
dc.identifier.doi http://dx.doi.org/10.1016/j.csbj.2019.06.017
dc.identifier.issn 2001-0370
dc.identifier.uri http://hdl.handle.net/10230/42277
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Computational and Structural Biotechnology Journal. 2019;17:963-71
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/SAF2017-83372-R
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/SAF2014-52228-R
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/BIO2017-85329-R
dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/AGL2014-52395-C2
dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/AGL2017-84097-C2-2-R
dc.rights © 2019 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.keyword Alzheimer's disease
dc.subject.keyword Amyloid
dc.subject.keyword Albumin
dc.subject.keyword β-Sheet
dc.subject.keyword Docking
dc.title Human albumin impairs amyloid β-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in alzheimer's disease
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions

Articles (Departament de Medicina i Ciències de la Vida)
Articles (Barcelona Institute for Global Health (ISGlobal) – Campus Mar)